Instrument Inactif

Communiqués Enzon Pharmaceuticals, Inc. Other OTC

Actions

ENZN

US2939041081

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	05/05/23	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	16/02/23	AQ
ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K)	06/01/23	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09/11/22	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04/08/22	AQ
ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	15/06/22	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	26/04/22	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	25/02/22	AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	05/11/21	AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	05/08/21	AQ
Enzon Pharmaceuticals : CONTINENTAL STOCK TRANSFER & TRUST COMPANY (Form 8-K)	08/06/21	PU
ENZON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	08/06/21	AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04/05/21	AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23/02/21	AQ
Enzon Pharmaceuticals : CEO Andrew Rackear to Retire, Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO	05/01/21	AQ
ENZON PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	04/01/21	AQ
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO	04/01/21	GL
ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	21/12/20	AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09/11/20	AQ
Enzon Pharmaceuticals : Announces Results of Rights Offering	21/10/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Enzon Pharmaceuticals, Inc. Other OTC

Actions

ENZN

US2939041081

Communiqués

Filtres